General Information of the Compound
| Compound ID |
CP0848486
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-2-(ethyloxy)-5-[3-(2-{[5-methyl-2-(methyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C42H43F2N7O3
|
||||||||||||||||||
| Molecular Weight |
731.848
|
||||||||||||||||||
| Canonical SMILES |
CCCN1CCC(c2cc(OC)c(Nc3nccc(-c4c(-c5ccc(OCC)c(C(=O)Nc6c(F)cccc6F)c5)nc5ccccn45)n3)cc2C)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C42H43F2N7O3/c1-5-19-50-21-16-27(17-22-50)29-25-36(53-4)34(23-26(29)3)47-42-45-18-15-33(46-42)40-38(48-37-12-7-8-20-51(37)40)28-13-14-35(54-6-2)30(24-28)41(52)49-39-31(43)10-9-11-32(39)44/h7-15,18,20,23-25,27H,5-6,16-17,19,21-22H2,1-4H3,(H,49,52)(H,45,46,47)
Show/Hide
|
||||||||||||||||||
| InChIKey |
YMSGHIRZTKWOJL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor